Stemonix and Atomwise Join Forces to Develop Small Molecules Targeting Rett Syndrome
StemoniX and Atomwise will work together to discover and develop small molecules that could be potential new therapies for people with Rett syndrome. This collaboration will take advantage of StemoniX’s human microOrgan platform and combines it with Atomwise’s artificial intelligence technology to expedite the development…